Calculation of proportional impairment ratio for subjective tests for the second-generation antihistamines in Japan.

Proportions of antibiotic choice congruence to DEGAM guideline for acute lower respiratory tract infection by diagnosis.

Eva Maria Kraus (3873898)
Steffen Pelzl (3873901)
Joachim Szecsenyi (14931)
Gunter Laux (72577)

March 2017

Proportions of antibiotic choice congruence to DEGAM guideline for acute lower respiratory tract ...

Cox proportional hazard analysis for the predictors of a composite clinical outcome in the total study population (n = 360).

Jeong-Eun Yi (6019565)
Junbeom Park (832072)
Hye-Jeong Lee (467748)
Dong Geum Shin (6019568)
Yookyung Kim (387797)
Minsuk Kim (1552345)
Kihwan Kwon (267623)
Wook Bum Pyun (6019571)
Young Jin Kim (207337)
Boyoung Joung (832076)

November 2018

Cox proportional hazard analysis for the predictors of a composite clinical outcome in the total stu...

Cox proportional hazard ratios (HRs) for under-five mortality incidence for each country.

Patrick Opiyo Owili (748818)
Miriam Adoyo Muga (748823)
Wen-Chi Pan (446012)
Hsien-Wen Kuo (3539411)

May 2017

Cox proportional hazard ratios (HRs) for under-five mortality incidence for each country.</p

Calculation of proportional impairment ratio for objective tests by dose.

Tatsuya Isomura (548724)
Takeshi Kono (674097)
Ian Hindmarch (674098)
Norimasa Kikuchi (462989)
Aya Murakami (432768)
Kyoko Inuzuka (548725)
Seiji Kawana (674099)

December 2014

a: Number of tests showing ‘impairment’ with the named antihistamine (AH). b: Number of tests sho...

Proportional impairment ratio calculation formula for an antihistamine.

Tatsuya Isomura (548724)
Takeshi Kono (674097)
Ian Hindmarch (674098)
Norimasa Kikuchi (462989)
Aya Murakami (432768)
Kyoko Inuzuka (548725)
Seiji Kawana (674099)

December 2014

a: Number of tests showing ‘impairment’ with the named antihistamine (AH). b: Number of tests sho...

Central Nervous System Effects of the Second-Generation Antihistamines Marketed in Japan -Review of Inter-Drug Differences Using the Proportional Impairment Ratio (PIR)-

Tatsuya Isomura (548724)
Takeshi Kono (674097)
Ian Hindmarch (674098)
Norimasa Kikuchi (462989)
Aya Murakami (432768)
Kyoko Inuzuka (548725)
Seiji Kawana (674099)

December 2014

<div>BackgroundSecond-generation antihistamines (AHs) have, in general, fewer sedative eff...

Number of test results showing impairment and no impairment for each AH by dose.

Tatsuya Isomura (548724)
Takeshi Kono (674097)
Ian Hindmarch (674098)
Norimasa Kikuchi (462989)
Aya Murakami (432768)
Kyoko Inuzuka (548725)
Seiji Kawana (674099)

December 2014

Number of test results showing impairment and no impairment for each AH by dose.</p

Sensitivity analysis of clinical cure rates, microbiological eradication rates and adverse events rates.

Yang Peng (486260)
Xiaohua Ye (381307)
Ying Li (38224)
Tao Bu (486261)
Xiaofeng Chen (392939)
Jiaqi Bi (486262)
Junli Zhou (131029)
Zhenjiang Yao (486263)

November 2013

Results were computed by omitting each study in turn. The two ends of the dotted lines represent ...

Number of diseased subjects recruited in control sample (A); Ratio of upper and lower bound of 95% confidence intervals of prevalence odds (B), in a case-base study of 200 distinct subjects (solid lines), 2000 distinct subjects (dashed lines) and 20000 distinct subjects (dotted lines).

Tina Tsz-Ting Chui (496929)
Wen-Chung Lee (73587)

December 2013

Number of diseased subjects recruited in control sample (A); Ratio of upper and lower bound of 95...

Comparative performances of scores.

Yasemin Cag (5793998)
Oguz Karabay (4054)
Oguz Resat Sipahi (5794001)
Firdevs Aksoy (5794004)
Gul Durmus (5794007)
Ayse Batirel (5794010)
Oznur Ak (5794013)
Zeliha Kocak-Tufan (5794016)
Aynur Atilla (4422778)
Nihal Piskin (5794019)
Turkay Akbas (5794022)
Serpil Erol (5794025)
Derya Ozturk-Engin (5794028)
Hulya Caskurlu (5794031)
Ugur Onal (5794034)
Haluk Erdogan (5794037)
Aslıhan Demirel (5794040)
Arzu Dogru (5794043)
Rezan Harman (5794046)
Aziz Ahmad Hamidi (5794049)
Derya Karasu (5794052)
Fatime Korkmaz (5794055)
Pınar Korkmaz (5794058)
Fatma Civelek Eser (5794061)
Yalcin Onem (5794064)
Sinem Cesur (5794067)
Musa Salmanoglu (5794070)
İlknur Erdem (5794073)
Hüsrev Diktas (5794076)
Haluk Vahaboglu (5794079)

September 2018

(A) H measure at different severity ratios. Severity ratio is the ratio of the cost of false positiv...

Percent (%) reduction in number of symptomatic cases, given influenza transmissibility parameter equivalent to Ro of 1.65 or 1.80.

Patrick Saunders-Hastings (3559859)
Bryson Quinn Hayes (4109998)
Robert Smith? (4110001)
Daniel Krewski (226807)

June 2017

Percent (%) reduction in number of symptomatic cases, given influenza transmissibility parameter ...

Geometric mean titers (A) and seropositive rates (B) of Japanese encephalitis neutralizing antibody on different year(s) post-booster dose.

Jin-ren Pan (3079326)
Ju-ying Yan (3079323)
Jia-yue Zhou (3079302)
Xue-wen Tang (3079311)
Han-qing He (3079317)
Rong-hui Xie (3079314)
Hai-yan Mao (3079320)
Yan-jun Zhang (3079305)
Shu-yun Xie (3079308)

August 2016

Geometric mean titers (A) and seropositive rates (B) of Japanese encephalitis neutralizing antibo...

Sensitivity of the tests among the patients having both the tests results, n = 408.

Liudmila Slogotskaya (6111866)
Elena Bogorodskaya (6111869)
Diana Ivanova (2679721)
Tatiana Sevostyanova (6111872)

December 2018

Sensitivity of the tests among the patients having both the tests results, n = 408.</p

Hazard ratio according to number of previous periods of sickness absence regardless of cause for the total sample and stratified for gender.

Liesbeth E. C. Wijnvoord (2805259)
Sandra Brouwer (840928)
Jan Buitenhuis (292897)
Jac J. L. van der Klink (444147)
Michiel R. de Boer (840929)

May 2016

Hazard ratio according to number of previous periods of sickness absence regardless of cause for ...

Disproportionality analysis for antihistamines with cases of cardiac arrest (CA) or sudden cardiac death (SCD).

Elisabetta Poluzzi (487411)
Emanuel Raschi (487410)
Brian Godman (487412)
Ariola Koci (487413)
Ugo Moretti (487414)
Marija Kalaba (487415)
Bjorn Wettermark (487417)
Miriam Sturkenboom (408749)
Fabrizio De Ponti (487418)

March 2015

NOTES: in italic, not statistically significant ROR; na = number of cases <3Disproportiona...

Proportions of antibiotic choice congruence to DEGAM guideline for acute lower respiratory tract infection by diagnosis.

Eva Maria Kraus (3873898)
Steffen Pelzl (3873901)
Joachim Szecsenyi (14931)
Gunter Laux (72577)

March 2017

Proportions of antibiotic choice congruence to DEGAM guideline for acute lower respiratory tract ...

Cox proportional hazard analysis for the predictors of a composite clinical outcome in the total study population (n = 360).

Jeong-Eun Yi (6019565)
Junbeom Park (832072)
Hye-Jeong Lee (467748)
Dong Geum Shin (6019568)
Yookyung Kim (387797)
Minsuk Kim (1552345)
Kihwan Kwon (267623)
Wook Bum Pyun (6019571)
Young Jin Kim (207337)
Boyoung Joung (832076)

November 2018

Cox proportional hazard analysis for the predictors of a composite clinical outcome in the total stu...

Cox proportional hazard ratios (HRs) for under-five mortality incidence for each country.

Patrick Opiyo Owili (748818)
Miriam Adoyo Muga (748823)
Wen-Chi Pan (446012)
Hsien-Wen Kuo (3539411)

May 2017

Cox proportional hazard ratios (HRs) for under-five mortality incidence for each country.</p

Calculation of proportional impairment ratio for objective tests by dose.

Tatsuya Isomura (548724)
Takeshi Kono (674097)
Ian Hindmarch (674098)
Norimasa Kikuchi (462989)
Aya Murakami (432768)
Kyoko Inuzuka (548725)
Seiji Kawana (674099)

December 2014

a: Number of tests showing ‘impairment’ with the named antihistamine (AH). b: Number of tests sho...

Proportional impairment ratio calculation formula for an antihistamine.

Tatsuya Isomura (548724)
Takeshi Kono (674097)
Ian Hindmarch (674098)
Norimasa Kikuchi (462989)
Aya Murakami (432768)
Kyoko Inuzuka (548725)
Seiji Kawana (674099)

December 2014

a: Number of tests showing ‘impairment’ with the named antihistamine (AH). b: Number of tests sho...

Central Nervous System Effects of the Second-Generation Antihistamines Marketed in Japan -Review of Inter-Drug Differences Using the Proportional Impairment Ratio (PIR)-

Tatsuya Isomura (548724)
Takeshi Kono (674097)
Ian Hindmarch (674098)
Norimasa Kikuchi (462989)
Aya Murakami (432768)
Kyoko Inuzuka (548725)
Seiji Kawana (674099)

December 2014

<div>BackgroundSecond-generation antihistamines (AHs) have, in general, fewer sedative eff...

Number of test results showing impairment and no impairment for each AH by dose.

Tatsuya Isomura (548724)
Takeshi Kono (674097)
Ian Hindmarch (674098)
Norimasa Kikuchi (462989)
Aya Murakami (432768)
Kyoko Inuzuka (548725)
Seiji Kawana (674099)

December 2014

Number of test results showing impairment and no impairment for each AH by dose.</p

Sensitivity analysis of clinical cure rates, microbiological eradication rates and adverse events rates.

Yang Peng (486260)
Xiaohua Ye (381307)
Ying Li (38224)
Tao Bu (486261)
Xiaofeng Chen (392939)
Jiaqi Bi (486262)
Junli Zhou (131029)
Zhenjiang Yao (486263)

November 2013

Results were computed by omitting each study in turn. The two ends of the dotted lines represent ...

Number of diseased subjects recruited in control sample (A); Ratio of upper and lower bound of 95% confidence intervals of prevalence odds (B), in a case-base study of 200 distinct subjects (solid lines), 2000 distinct subjects (dashed lines) and 20000 distinct subjects (dotted lines).

Tina Tsz-Ting Chui (496929)
Wen-Chung Lee (73587)

December 2013

Number of diseased subjects recruited in control sample (A); Ratio of upper and lower bound of 95...

Comparative performances of scores.

Yasemin Cag (5793998)
Oguz Karabay (4054)
Oguz Resat Sipahi (5794001)
Firdevs Aksoy (5794004)
Gul Durmus (5794007)
Ayse Batirel (5794010)
Oznur Ak (5794013)
Zeliha Kocak-Tufan (5794016)
Aynur Atilla (4422778)
Nihal Piskin (5794019)
Turkay Akbas (5794022)
Serpil Erol (5794025)
Derya Ozturk-Engin (5794028)
Hulya Caskurlu (5794031)
Ugur Onal (5794034)
Haluk Erdogan (5794037)
Aslıhan Demirel (5794040)
Arzu Dogru (5794043)
Rezan Harman (5794046)
Aziz Ahmad Hamidi (5794049)
Derya Karasu (5794052)
Fatime Korkmaz (5794055)
Pınar Korkmaz (5794058)
Fatma Civelek Eser (5794061)
Yalcin Onem (5794064)
Sinem Cesur (5794067)
Musa Salmanoglu (5794070)
İlknur Erdem (5794073)
Hüsrev Diktas (5794076)
Haluk Vahaboglu (5794079)

September 2018

(A) H measure at different severity ratios. Severity ratio is the ratio of the cost of false positiv...

Percent (%) reduction in number of symptomatic cases, given influenza transmissibility parameter equivalent to Ro of 1.65 or 1.80.

Patrick Saunders-Hastings (3559859)
Bryson Quinn Hayes (4109998)
Robert Smith? (4110001)
Daniel Krewski (226807)

June 2017

Percent (%) reduction in number of symptomatic cases, given influenza transmissibility parameter ...

Geometric mean titers (A) and seropositive rates (B) of Japanese encephalitis neutralizing antibody on different year(s) post-booster dose.

Jin-ren Pan (3079326)
Ju-ying Yan (3079323)
Jia-yue Zhou (3079302)
Xue-wen Tang (3079311)
Han-qing He (3079317)
Rong-hui Xie (3079314)
Hai-yan Mao (3079320)
Yan-jun Zhang (3079305)
Shu-yun Xie (3079308)

August 2016

Geometric mean titers (A) and seropositive rates (B) of Japanese encephalitis neutralizing antibo...

Sensitivity of the tests among the patients having both the tests results, n = 408.

Liudmila Slogotskaya (6111866)
Elena Bogorodskaya (6111869)
Diana Ivanova (2679721)
Tatiana Sevostyanova (6111872)

December 2018

Sensitivity of the tests among the patients having both the tests results, n = 408.</p

Hazard ratio according to number of previous periods of sickness absence regardless of cause for the total sample and stratified for gender.

Liesbeth E. C. Wijnvoord (2805259)
Sandra Brouwer (840928)
Jan Buitenhuis (292897)
Jac J. L. van der Klink (444147)
Michiel R. de Boer (840929)

May 2016

Hazard ratio according to number of previous periods of sickness absence regardless of cause for ...

Disproportionality analysis for antihistamines with cases of cardiac arrest (CA) or sudden cardiac death (SCD).

Elisabetta Poluzzi (487411)
Emanuel Raschi (487410)
Brian Godman (487412)
Ariola Koci (487413)
Ugo Moretti (487414)
Marija Kalaba (487415)
Bjorn Wettermark (487417)
Miriam Sturkenboom (408749)
Fabrizio De Ponti (487418)

March 2015

NOTES: in italic, not statistically significant ROR; na = number of cases <3Disproportiona...

Proportions of antibiotic choice congruence to DEGAM guideline for acute lower respiratory tract infection by diagnosis.

Eva Maria Kraus (3873898)
Steffen Pelzl (3873901)
Joachim Szecsenyi (14931)
Gunter Laux (72577)

March 2017

Proportions of antibiotic choice congruence to DEGAM guideline for acute lower respiratory tract ...

Cox proportional hazard analysis for the predictors of a composite clinical outcome in the total study population (n = 360).

Jeong-Eun Yi (6019565)
Junbeom Park (832072)
Hye-Jeong Lee (467748)
Dong Geum Shin (6019568)
Yookyung Kim (387797)
Minsuk Kim (1552345)
Kihwan Kwon (267623)
Wook Bum Pyun (6019571)
Young Jin Kim (207337)
Boyoung Joung (832076)

November 2018

Cox proportional hazard analysis for the predictors of a composite clinical outcome in the total stu...

Cox proportional hazard ratios (HRs) for under-five mortality incidence for each country.

Patrick Opiyo Owili (748818)
Miriam Adoyo Muga (748823)
Wen-Chi Pan (446012)
Hsien-Wen Kuo (3539411)

May 2017

Cox proportional hazard ratios (HRs) for under-five mortality incidence for each country.</p

Calculation of proportional impairment ratio for subjective tests for the second-generation antihistamines in Japan.

Abstract

Extracted data

Calculation of proportional impairment ratio for subjective tests for the second-generation antihistamines in Japan.

Abstract

Extracted data

Related items

Related items